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Abstract Oocyte loss has a significant impact on fertility
and somatic health. Yet, we know little about factors that
impact this process. We sought to identify genetic variants
associated with ovarian reserve (oocyte number as mea-
sured by antral follicle count, AFC). Based on recently
published genome-wide scans that identified loci associ-
ated with age of menopause, we also sought to test our
hypothesis that follicle number and menopausal age share
underlying genetic associations. We analyzed menopause-
related variants for association with follicle number in an
independent population of approximately 450 reproduc-
tive-aged women of European and African ancestry; these
women were assessed for AFC, anthropometric, clinical,
and lifestyle factors. One SNP strongly associated with
later menopausal age in Caucasian women (?1.07 ± 0.11
years) in previous work was also associated with higher
follicle counts in Caucasians (?2.79 ± 1.67 follicles) in
our study. This variant is within the Minichromosome
Maintenance Complex Component 8 (MCM8) gene, which
we found was expressed within oocytes in follicles of the
human ovary. In genome-wide scans of AFC, we also
identified one marginally genome-wide and several nomi-
nally significant SNPs within several other genes associ-
ated with follicle number in both ethnic groups. Further,
there were overlapping variants associated with multiple
ovarian reserve markers (AFC, serum hormone levels,
menopausal age). This study provides the first evidence for
direct genetic associations underlying both follicle number
and menopause and identifies novel candidate genes.
Genetic variants associated with ovarian reserve may
facilitate discovery of genetic markers to predict repro-
ductive health and lifespan in women.
Introduction
Infertility is remarkably common in humans compared to
other species and affects nearly 15 % of reproductive-aged
couples (Hull et al. 1985; Menken and Larsen 1994;
Speroff 2005). In some cases, especially in the male,
infertility is linked to genetic defects in germ cell devel-
opment that manifest as reduced quantity or quality of
sperm (Hull et al. 1985; Reijo Pera et al. 1995; Xu et al.
2001). However, other than genetic loci identified in cer-
tain reproductive disorders and animal models, genes
involved in human female fertility, in particular the for-
mation and maintenance of oocytes, have yet to be dis-
covered. Indeed, to date, no genome-wide association
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studies (GWASs) have directly investigated follicle
(oocyte) number in women.
In the human female, the number of oocytes increases
initially in fetal development and then declines, from an
established pool, beginning in prenatal life. Early in
development (*3 weeks post-conception), a small popu-
lation of founder cells, the primordial germ cells (PGCs),
migrates to the genital ridges and rapidly proliferates to
about 5–7 million germ cells. These PGCs, now termed
gonocytes, subsequently begin meiosis and differentiate
within the developing ovaries (Larsen 1997). The meiotic
oogonia, arrested in prophase I, become surrounded by
supportive somatic (granulosa) cells to form the follicles.
Through the process of atresia (cell death), oocyte and
follicle loss results in about 1 million follicles within the
ovaries at birth (Block 1953). Over the course of a
woman’s lifetime oocytes may be recruited to resume
meiosis (to mature and undergo ovulation), remain quies-
cent, or be lost through atresia, as is the case for the vast
majority of oocytes. By the time of puberty approximately
500,000 follicles remain, declining to 10,000–50,000 by
the late 30s; eventually, the follicle pool is exhausted and
menopause ensues (Block 1952, 1953; Faddy et al. 1992;
Hansen et al. 2008; Richardson et al. 1987; te Velde and
Pearson 2002; te Velde et al. 1998).
The age-related decline in the oocyte pool and the
associated increase in chromosomal aneuploidies and
miscarriage rates have important implications for under-
standing human oocyte biology and fertility (Hunt and
Hassold 2008). There is great variability in the quantity and
quality of the oocyte pool, or ovarian reserve, among
women. There is also wide variability in reproductive
potential and the timing of reproductive events such as
menarche (onset of the first menstrual period) and meno-
pause, both of which likely have strong genetic and envi-
ronmental influences (Cramer et al. 1995; de Bruin et al.
2001; Gosden et al. 2007; Snieder et al. 1998; te Velde and
Pearson 2002). Family and twin studies indicate that
menarche and menopause have high heritability
(*50–80 %) and genetic components (de Bruin et al.
2001; Meyer et al. 1991; Murabito et al. 2005; Snieder
et al. 1998). Furthermore, the process of ovarian aging and
timing of reproductive events are important risk factors for
various diseases including breast and ovarian cancer, car-
diovascular disease, osteoporosis, and overall mortality
(Cooper and Sandler 1998; Hartge 2009). However, due to
the inaccessibility of early human development we know
little of the genes and variants involved in oocyte devel-
opment and establishment of the ovarian reserve. No
studies have explored the relationship between follicle
number, menopause, and associated genes. This is likely
because there are few studies examining follicle number in
normo-ovulatory women and it is nearly impossible to
study follicle number and menopause in the same cohort of
women—in all previous studies on menopause, data on
follicle number were not available or would have likely
been too low to measure.
An underlying objective of this work was to identify
genetic markers of ovarian reserve that would enable more
accurate long-range predictions about reproductive and
somatic health. Here, we used a community-based cohort
of reproductively normal women of European and African
ancestry of the OVA (Ovarian Aging) Study to investigate
genetic loci associated with the phenotypic traits of follicle
number and menopause. We hypothesized that ovarian
reserve and reproductive lifespan are closely associated
and largely determined by multiple genetic factors that may
impact early germ cell and follicle formation, or rate of
follicle loss. We tested the newly identified variants asso-
ciated with menopausal age in previous cohorts for asso-
ciation with antral follicle number (a stage of oocyte
readily observed by ultrasound) and other ovarian reserve
markers in this completely independent population of
women. Additionally, we conducted a GWAS to determine
whether specific variants may be associated with the
ovarian reserve as assessed by antral follicle count, in these
ethnic groups. Finally, the expression of identified candi-
date genes was examined in human ovarian tissue.
Subjects and methods
Study population
The study cohorts included 273 Caucasian women and 245
African American women, aged 25–45 years. All subjects
were ovulatory with regular menstrual cycles between 22
and 35 days in length, and enrolled in the OVA Study (an
ongoing, multi-ethnic, community-based study). Women
with oligo- or an-ovulation, surgically diagnosed endo-
metriosis, premature ovarian failure (POF), polycystic
ovary syndrome (PCOS), hyperandrogenism, or a history
of uterine or ovarian surgery were excluded. Women were
also excluded if they had cysts, fibroids or other abnor-
malities that obscured AFC measurements. Ethnicity was
by self-report but required both parents to be of the same,
identified ethnicity. Of the 273 Caucasian women, 21 were
excluded, and of the 245 African American women, 27
were excluded, due to anatomical or ovarian problems
(Online Resource Table 1). For a detailed description of
the OVA Study population and additional information on
all methods see the Online Resource material. This work
was approved by the Institutional Review Boards at Kaiser
Permanente, University of California San Francisco, and
Stanford University, and informed consent was obtained
for all subjects.
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Phenotypes and covariates
Antral follicle counts were performed as previously
described (Rosen et al. 2010b; Schuh-Huerta et al. 2012).
Briefly, all subjects underwent transvaginal ultrasound
assessment of ovarian volumes and AFC, performed on
days 2–4 of their menstrual cycle. Blood samples were
collected at the same time and used for all serum hormonal
assays and genotyping as in previous work (Schuh-Huerta
et al. 2012). Subjects completed a comprehensive ques-
tionnaire and physical exam to obtain detailed health,
reproductive, anthropometric (body), lifestyle, and demo-
graphic information.
Genotyping
Genotypic data for a total of 249 Caucasian and 203 African
American women were obtained using the Genome-Wide
Human SNP Array 6.0 (Affymetrix, Santa Clara, CA, USA).
As previously published (Schuh-Huerta et al. 2012), genomic
DNA was extracted and purified from white blood cells using
the QIAamp DNA Blood Maxi Kit (Qiagen, Venlo, The
Netherlands) according to the manufacturer’s instructions.
The DNA ligation, hybridization, and microarray scanning
steps were completed according to the manufacturer’s pro-
tocols. Briefly, 500 ng total genomic DNA was prepared at
50 ng/ll using the Nanodrop ND-1000 Spectrophotometer
(Nanodrop Technologies, Wilmington, DE, USA), aliquoted,
digested into fragments, ligated to adaptors, amplified by
PCR, and purified using polystyrene beads. The amplified
DNA was fragmented (\180 bp/fragment), labeled, hybrid-
ized to the microarray, stained, and washed using the Fluidics
Station 450, and then scanned with the GeneChip Scanner
3000 7G (Affymetrix).
In the Caucasian group, after removal of one sample fail-
ing quality control (QC), two samples failing ethnicity vali-
dation, and one duplicate sample, of the final 245 samples that
passed QC and filter criteria, the mean contrast QC was
1.93 ± 0.046, the QC call rate was 94.0 ± 0.2 %, and the
overall sample call rate was 98.0 ± 0.07 %. In the African
American group, after removal of one sample failing eth-
nicity validation, of the final 202 samples the mean contrast
QC was 2.22 ± 0.035, the QC call rate was 97.0 ± 0.1 %,
and the overall sample call rate was 99.4 ± 0.08 %. SNPs
were genotyped using Genotyping Console (GTC) v.4.0
software (http://www.affymetrix.com). All SNP locations are
referenced to the National Center for Biotechnology Infor-
mation (NCBI) human genome build 37, February 2009, and
dbSNP build 131, April 2010 (http://www.ncbi.nlm.
nih.gov/projects/SNP). Gene names provided in all tables
and text represent the HUGO gene symbols (http://www.gene
names.org/).
Population structure
A principal component analysis (PCA) using singular value
decomposition was used for ethnicity validation and tests of
population structure. Subjects of the HapMap CEU (Utah
residents with N. and W. European ancestry from the CEPH
collection) and YRI cohorts (Yoruban in Ibadan, Nigeria)
(International HapMap Consortium 2005) (http://hapmap.
ncbi.nlm.nih.gov/) were genotyped using the same genotyp-
ing platform, for comparison with the OVA cohorts, as
described (Schuh-Huerta et al. 2012). PCA was performed
using the statistical program R v.2.11.1 (http://www.r-
project.org/) (Gentleman et al. 2008) and BEAGLE v3.0.2
(http://www.stat.aukland.ac.nz/*bbrowning/beagle/beagle)
(Browning and Browning 2007; Browning 2006). Fraction of
African ancestry was also determined and allele frequency
spectra were compared between the Caucasian and CEU, and
African American and CEU/YRI cohorts to analyze allele
composition and population homogeneity.
Immunofluorescence
To examine the expression of MCM8 and the established
germ cell/oocyte marker VASA (DEAD (Asp-Glu-Ala-Asp)
Box Polypeptide 4, DDX4) within the ovary, human ovar-
ian tissue was freshly harvested and donated from a
37-year-old healthy Caucasian woman. She had no known
ovarian dysfunction or other diseases. Human testicular
tissue was also obtained from a 29-year-old healthy Cau-
casian male with no reported reproductive or somatic dis-
eases. The tissues were fixed in 10 % neutral buffered
formalin, embedded in paraffin, sectioned (at a thickness
of 5–7 lm), and mounted on positively charged slides
(Zyagen, San Diego, CA, USA). The sections were washed
three times in xylene for 4 min each to promote dewaxing,
followed by successive ethanol washes for rehydration:
three times in 100 % ethanol for 4 min, two times in 95 %
ethanol for 3 min, 90 % ethanol for 3 min, 85 % ethanol
for 3 min, 80 % ethanol for 3 min, 70 % ethanol for 3 min,
50 % ethanol for 3 min, and dH2O for 3 min. Antigen
retrieval was performed following dewaxing and rehydra-
tion, by incubating the sections 10 min in prewarmed cit-
rate buffer (5 mM trisodium citrate, 4.4 mM HCl, pH 6.0)
then boiling in citrate buffer in a rice cooker for
25–30 min. Slides were air-dried, traced with a PAP pen
(Sigma-Aldrich, St. Louis, MO, USA), and rinsed three
times with PBS (Sigma-Aldrich). Tissues were then per-
meabilized in 0.2 % Triton X-100 (Sigma-Aldrich) in PBS
for 15 min at room temperature. Slides were washed three
times in PBS and blocked to prevent non-specific binding
in 4 % normal donkey serum (Jackson ImmunoResearch
Labs, Inc., West Grove, PA, USA) in PBS overnight at
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4 C in a humid chamber. The slides were then incubated
for 1 h at room temperature with the rabbit anti-human
MCM8 primary antibody (SC99038; Santa Cruz Biotech-
nology Inc., Santa Cruz, CA, USA) at dilutions of 1:100
and 1:200, and the goat anti-human VASA antibody
(AF2030; R&D Systems, Minneapolis, MN, USA) at
1:250, in PBS with 4 % donkey serum. As a negative
control, adjacent sections were incubated with the rabbit
and goat non-immune isotype IgGs at 1:500 (Invitrogen,
Grand Island, NY, USA) in place of the primary antibody.
As an additional biological negative control, mature human
neurons derived and cultured in vitro were stained for
MCM8 and VASA using the same antibodies and proto-
cols. Slides were washed three times with PBS supple-
mented with 0.1 % Tween-20 (PBST) and primary signals
were detected using the donkey anti-rabbit secondary
antibody conjugated to Alexa Fluor-488 and the anti-goat
secondary antibody conjugated to Alexa-Fluor-594 (Invit-
rogen) at 1:500 in PBS with 4 % donkey serum for 1 h at
room temperature in the dark. Slides were washed three
times with PBST, one time with PBS, stained with DAPI
(1:5,000) for 1 h at 4 C in the dark, mounted with cov-
erslips, and imaged on a Zeiss LSM700 Meta Inverted laser
scanning confocal microscope and a Leica DMI 6000B
Inverted fluorescence microscope. The same microscopy
settings including pinhole, laser power, exposure time, and
gain were used for all sections. All fluorescence images
were processed in ImageJ (NIH).
Statistical analyses
Phenotypic and covariate analysis
Descriptive statistics were calculated for AFC and all
demographic, anthropometric, hormonal, reproductive, and
lifestyle variables. The relationship between each variable
and AFC was analyzed in linear regression analyses. Phe-
notypes and covariates were also independently compared
between Caucasian and African American women, using
the Student’s t test or Welch 2-Sample t test within R
v.2.11.1 (Gentleman et al. 2008). Covariates that were
significantly associated with follicle number were con-
trolled for in downstream GWA analyses.
SNP association analysis
In candidate SNP studies, we searched for and analyzed all
previously reported top SNPs associated with menopause
that had corresponding markers on our microarrays. A total
of four SNPs significant at the genome-wide level
(P \ 5.0 9 10-8) and replicated in previous work were
tested for association with follicle count in both the Cau-
casian and African American cohorts. Final P values were
corrected for the number of tests and considered statisti-
cally significant at a level of\0.05. Effect sizes in terms of
direction (increase/decrease in AFC or menopausal age)
and magnitude (total difference in the mean number of
follicles or menopausal age in years) for the effect allele/
genotype were compared for all variants tested. As
approximately one antral follicle is lost each year of female
age and presumably women with fewer antral follicles
enter menopause sooner, quantitative comparisons can be
made between the differences in the mean AFC and mean
menopausal age for all effect alleles.
Both candidate SNP and GWA analyses were performed
using the Fisher’s exact test for single-marker (SNP) and
multiple-marker (haplotype) association. The correlation
coefficients and effect sizes (the difference in the mean
number of follicles ± SEM from the regression fit) were
then determined by regression analyses for a given allele or
genotype. Final P values were computed and analyzed at
both the chromosome- and genome-wide levels, corrected
by permutation testing and Bonferroni correction, due to
our sample size/power constraints. For detailed power
calculations refer to Online Resource, ‘‘Subjects and
methods.’’ Custom-made script and algorithms were writ-
ten and employed within R to mediate streamlined data
analyses.
Results
Characteristics of study population
As shown in Fig. 1 and Online Resource Figure 1, AFC
measurements, blood samples, and questionnaires were
collected from 273 Caucasian women and 245 African
American women. After applying quality control filters and
removal of women with anatomical or ovarian abnormali-
ties, a total of 245 women of genetically inferred European
ancestry and 202 women of genetically inferred African
ancestry were included in the final analysis and genotyped
for 909,622 SNPs. The relevant demographics of the study
population used in genetic association analyses are
described in Table 1. The average age was 35.4 ± 0.3 and
35.6 ± 0.4 (mean ± SEM) years for the Caucasian and
African American cohorts, respectively, and the ages were
normally distributed with a slight left-ward shift. AFCs
ranged from 1 to 53 with a mean of 15.4 ± 0.6 in the
Caucasian cohort, and from 2 to 52 with a mean of
15.6 ± 0.7 in the African American cohort. As reported in
our recent work (Rosen et al. 2010b), in the women gen-
otyped in this study AFC was negatively associated with
age. The relationship between AFC and age in both Cau-
casian and African American women was best fit by simple
linear regression and power [AFC = A ? B 9 (age)C]
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models. As shown in Fig. 1B, C, AFC declined with female
age, with a gradual acceleration of follicle loss beginning
around age 40. This pattern was similar in both Caucasian
and African American women. The average decline in AFC
was about 0.93 follicles/year in Caucasians and 0.76 fol-
licles/year in African Americans, although there was great
variability among both groups. There were no statistically
significant differences between the mean values or
regressions of AFC verses age between the two racial
groups. Further, there was no association between per-
centage of African ancestry and AFC as determined from
PCA and regression analyses, as described below. How-
ever, there was a trend for higher follicle numbers and a
greater distribution of follicle counts above 35, as well as
greater variability in the African American women
(Fig. 1C).
Population structure
In PCA tests of population stratification there was a close
clustering of the Caucasian cohort with the HapMap CEU
cohort and the African American cohort with the HapMap
YRI cohort (Online Resource Figure 2). Two Caucasian
samples were identified as non-Caucasian, and clustered
with the African American cohort, while one African
American sample was identified as Caucasian and clustered
with the Caucasian and CEU populations (Online Resource
Figure 2; Table 1). These individuals self-identified as the
race they were originally categorized as; outliers unlikely
resulting from sampling error. The Caucasian cohort dis-
played an allele frequency spectrum nearly identical to the
CEU population, while the African American cohort dis-
played an allele frequency spectrum representing a com-
bination of 80 % YRI and 20 % CEU alleles which is
exactly the allele spectra of individuals of African ancestry
living in America (Online Resource Figure 2B). Moreover,
both the Caucasian and CEU, and the African American
and YRI/CEU cohorts, respectively, showed highly similar
genotype frequencies and minor allele frequencies, vali-
dating the homogeneity and ethnic identity of our cohorts
(Online Resource Figure 2B). In regression analyses using
PC1 and PC2 scores (fraction of African ancestry), when
controlling for female age, AFC was not associated with
African ancestry (P = 0.57 and 0.81).
Genetic association analysis
To examine the association between follicle number and
reproductive lifespan we analyzed the relationship between
menopause-related SNPs identified in previous work, with
follicle number and other ovarian reserve markers, in this
cohort of women. This strategy aimed to provide both
validation and a test of the prediction that these two traits
share underlying genetic loci. We reasoned that the large,
well-characterized post-menopausal populations of these
previous studies might provide some validation of our
findings and with our data, critical insight on the genetic
links between follicle number and menopause. We pre-
dicted an approximate 1:1 ratio between the difference in
menopausal age:follicle number for these variants, with
effects going in the same directions for both traits if they
are functionally related—and this is indeed the case.
Fig. 1 Measurements of antral follicle count in women. A Transvag-
inal ultrasound image of the left ovary of one woman showing antral
follicles ranging in size (arrow indicates one large antral follicle of
8–10 mm). Total antral follicle counts obtained from B Caucasian and
C African American women of the entire study population indicate
that AFC decreases with age, but is highly variable between women.
The data were fit with the power model (dashed line) and linear
regression model (solid line). The corresponding correlation coeffi-
cients (R2) and linear equations are shown
Hum Genet (2012) 131:1709–1724 1713
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A total of four genome-wide significant SNPs from three
previous publications (He et al. 2009; Murray et al. 2010;
Stolk et al. 2009) were tested for association with follicle
count using the Fisher’s exact test in both the Caucasian
(n = 223) and the African American (n = 202) cohorts. As
shown in Table 2, SNP rs16991615 at loci 20p12.3,
strongly associated with a later menopausal age of
?1.07 ± 0.11 years per copy of the minor allele (He et al.
2009), was significantly associated with higher follicle
counts of ?2.79 ± 1.67 follicles for the corresponding
genotype in the Caucasian women (P = 0.018). This SNP
was within the MCM8 (Minichromosome Maintenance
Complex Component 8) gene and was associated with a
delayed age of menopause at the genome-wide level in
approximately 9,000 women of the Nurse’s Health and
Women’s Genome Health Studies (He et al. 2009), 3,000
women of the Rotterdam Baseline and Twins UK Studies
(Stolk et al. 2009), and replicated in approximately 2,000
women of the Breakthrough Generations and ReproGen
Studies (Murray et al. 2010).
Interestingly, although none of the other menopausal
SNPs that reached genome-wide significance in previous
studies was independently significant at the 0.05 level in
our study, all of them exhibited regression coefficients that
were similar in magnitude and direction. There were highly
similar allele/genotype effects on both menopausal age and
follicle number, with a concordance between later meno-
pausal age and higher follicle counts, and earlier meno-
pausal age and lower follicle counts (Table 2). As AFC
declines by *1 follicle per year of female age, this is
consistent with the observed associations between AFC and
menopausal age for all variants tested. These results, and
the ability to discover multiple variants associated with
both menopausal age and follicle number, are likely limited
by our sample size. Nevertheless, these results demonstrate
for the first time a plausible functional link between
Table 1 Demographics of study population and variables included in association analysis of antral follicle count
Caucasians African Americans
Mean ± SEMa n R2b Mean ± SEMa n R2b
Age 35.4 ± 0.3 245 20.27 35.6 ± 0.4 202 20.20
AFC 15.4 ± 0.6 245 1.00 15.6 ± 0.7 202 1.00
Height (cm) 166.4 ± 0.4 (50600)* 243 0.00020 164.3 ± 0.5 (50500)* 202 0.015
Weight (kg) 67.7 ± 1.0 (149 lbs)* 243 0.0034 87.0 ± 1.7 (192 lbs)* 202 -0.0048
BMI 24.4 ± 0.4* 243 0.0046 32.1 ± 0.6* 201 -0.012
Age at Menarche 12.8 ± 0.09* 243 -0.022 12.1 ± 0.1* 200 -2 9 10-6
Cycle length (days) 29.1 ± 0.1 243 0.0014 29.6 ± 0.2 200 0.0077
Parity (C1 birth) 36 % 243 52 % 200
Asterisks indicate significant differences between Caucasian and African American women (P \ 0.001)
a Values are shown as mean ± SEM or percent of the cohort
b Correlation coefficient is based on regression with AFC. Bold values indicate highly significant correlation (P \ 0.001)
Table 2 Associations between known menopause-related SNPs and follicle number in Caucasian women of OVA Study





rs16991615 MCM8 20p12.3 A/G 0.07 ?1.07 ± 0.11 ?2.79 ± 1.67 0.0045 (0.018)
rs4806660 TMEM150B 19q13.42 G/A 0.37 -0.41 ± 0.030 -1.77 ± 1.32 0.43 (1)
rs691141 HK3 5q35.2 A/G 0.48 ?0.36 ± 0.052 ?3.16 ± 1.32 0.34 (1)
rs2153157 SYCP2L 6p24.2 A/G 0.45 ?0.29 ± 0.052 ?2.21 ± 1.21 0.57 (1)
Genes: MCM8 minichromosome maintenance complex component 8, TMEM150B transmembrane protein 150B, HK3 hexokinase 3 (White cell),
SYCP2L synaptonemal complex protein 2-like
Bold value indicates significance of P \ 0.05
P values are based on the Fisher’s exact test for SNP association with antral follicle count; values in parentheses denote final corrected P values
a SNPs at each locus are those published for association with menopausal age, rather than those with the strongest signal for follicle count
b Minor/major allele
c The difference in mean (±SEM) age at menopause in years per copy of the SNP minor allele as previously reported
d The difference in mean (±SEM) number of follicles for the corresponding genotype calculated from the regression analysis
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menopausal genetic variants and oocyte number in women
of European ancestry.
To further analyze the potential association of age at
menopause with ovarian reserve, we examined the variants
linked with menopausal age for association with several
well-known markers of ovarian reserve, including AFC,
anti-Mullerian horomone (AMH), and follicle-stimulating
hormone (FSH). We found that the four menopausal SNPs in
addition to SNPs in the 50-kb region surrounding the lead
SNP were not independently associated with follicle number
in the African American cohort (Online Resource Table 2).
And in several cases the directions and magnitudes of effects
were inconsistent between previous studies in Europeans
and current studies in African Americans. This is not entirely
unexpected due to the differences in ancestral background,
LD structure, haplotypes, and allelic heterogeneity across
different racial/ethnic groups. Because the minor allele fre-
quency (MAF) for the MCM8 SNP is so much lower in the
African American group (i.e. 0.01) compared to the Cau-
casian group, these results should be interpreted with cau-
tion. However, variants in the regions immediately flanking
the top menopausal SNP, rs16991615, had significantly low
P values associated with AMH and FSH, in both ethnic
groups. Seven to 11 variants had P values of 1.23 9 10-2 to
1.38 9 10-3 and were within a flanking region of 35–89
SNPs. These variants were also 2.5–10 times more likely
than expected, based on P value distributions. Notably, the
majority of these variants were linked with AMH, FSH, and/
or AFC, and were replicated in both Caucasian and African
American women. Several of these overlapping variants
(rs237416, rs6053673, rs11700084, rs4618122, rs4407314,
rs11908294, and rs6053911) were within the MCM8,
C20orf196 (Chromosome 20 Open Reading Frame 196), and
FERMT1 (Fermitin Family Member 1) genes. Together,
these results provide greater validation and evidence for
genetic associations underlying ovarian reserve and meno-
pausal age in women of multiple ethnicities.
In genome-wide analyses, we examined associations
with AFC in the independent Caucasian and African
American cohorts. SNPs with MAF of \1 %, missing call
rate (MCR) of [5 %, significant deviation from Hardy–
Weinberg Equilibrium (HWE) and high discordance rates
were excluded, leaving 677,261 SNPs in the Caucasian
cohort and 738,185 SNPs in the African American cohort
that were independently tested for association with AFC.
Figure 2 shows the Manhattan plots depicting association
results across the genome in the Caucasian (Fig. 2A, B)
and African American (Fig. 2C, D) cohorts.
In the Caucasians, the top five genetic loci were on
chromosome 7, 12 (2 SNPs), 20, 13, and 8 (Fig. 2). One
SNP, rs17835738, located at 7q36.1, just upstream of the
Leucine Rich Repeat Containing 61 (LRRC61) gene and
within the ARP3 Actin-Related Protein 3 Homolog C
(ACTR3C) gene, was strongly associated with AFC at the
chromosome-wide level (P = 0.006; MAF = 0.08) and
was the only variant marginally associated at the genome-
wide level (P = 7.9 9 10-8; Table 3; assuming a genome-
wide threshold of P \ 5.0 9 10-8). The other five SNPs
were nominally associated with AFC (P = 9.76 9 10-7 to
2.77 9 10-6; MAFs = 0.08–0.43). As shown in Fig. 3,
graphical representation of SNP genotypes with their cor-
responding phenotypes allows visualization of the associ-
ation with low or high follicle counts. The most significant
variant, rs17835738, was associated with mean increases of
6.9 ± 2.0 and 8.2 ± 2.3 follicles for the GG and GC
genotypes, respectively, compared to 0.3 ± 0.5 follicles
for the CC genotype (Fig. 3; Table 3). Variants rs7305642
and rs2417903 at 12p13.2 are located immediately down-
stream of the Killer Cell Lectin-Like Receptor Subfamily A,
Pseudogene 1 (KLRAP1). Variant rs7305642 was associ-
ated with an increase of 4.7 ± 1.0 follicles and a decrease
of 2.2 ± 1.0 follicles for the AA and GG genotypes,
respectively. Variant rs2417903 was associated with a
decrease of 2.2 ± 1.0 and an increase of 4.7 ± 1.0 follicles
for the AA and TT genotypes, respectively. Variant
rs175810 at 20p12.1 is in an intronic region of the MACRO
Domain Containing 2 (MACROD2) gene and was associ-
ated with a decrease of 3.1 ± 1.3 follicles and an increase
of 2.5 ± 0.7 follicles for the GG and CC genotypes,
respectively. Of the last two nominal variants, rs4769524 at
13q12.13, is located upstream of the G Protein-Coupled
Receptor 12 (GPR12) gene and rs1382566 at 8p23.1, is
located within an intron of the B Lymphoid Tyrosine
Kinase (BLK) gene.
In replication studies, the top variants associated with
AFC were examined in the African American population as
an independent replication cohort. The top SNP
rs17835738 was not significant at a P \ 0.05 level.
Although, this may be due to differences in minor allele
frequencies (0.08 vs. 0.01 in the Caucasians and African
Americans, respectively). However, in careful analyses of
the SNPs flanking this variant and that of the other top six
hits associated with AFC, it was found that for several of
these there were clusters of nearby SNPs (12–150 SNPs
away) that had significantly low P values of 1.9 9 10-2 to
2.1 9 10-3. Based on observed P value distributions there
was a two- to sixfold greater number of these variants than
expected by chance. This provides some validation of these
genetic loci in the African American cohort.
In the African American cohort, the top three loci linked
with AFC were localized to chromosome 13, 18, and 12
(Fig. 2C, D). Variant rs17191595 at 13q21.1, downstream
of the Protocadherin 17 (PCDH17) and Diaphanous
Homolog 3 (Drosophila) (DIAPH3) genes, was associated
with AFC at the chromosome-wide level (P = 0.049;
MAF = 0.08), but not at the genome-wide level (Table 3).
Hum Genet (2012) 131:1709–1724 1715
123
Fig. 2 Summary of GWA results for follicle number. Manhattan
plots of the A, C uncorrected and B, D corrected P values of the
Fisher’s exact test in Caucasian (A, B) and African American (C,
D) women. Each point represents a SNP from the single SNP and
haplotype tests of association across the genome remaining after
quality control and SNP filtering. The red dashed lines indicate
P values of 5.0 9 10-8 (uncorrected) and 0.05 (chromosome
corrected), significance level
Table 3 Variants associated with follicle number
SNP Chr Gene Position Cytoband Allelesa MAF AA effectb AB effectb BB effectb P value
Caucasians
rs17835738 7 LRRC61 149992098 q36.1 G/C 0.08 6.89 ± 1.95 8.17 ± 2.31 0.29 ± 0.54 7.90 3 1028
rs7305642 12 KLRAP1 10705382 p13.2 G/A 0.44 -2.24 ± 0.99 0.10 ± 0.72 4.67 ± 0.98 9.76 9 10-7
rs2417903 12 KLRAP1 10704691 p13.2 A/T 0.43 -2.24 ± 0.98 0.10 ± 0.72 4.67 ± 0.98 9.76 9 10-7
rs175810 20 MACROD2 15827930 p12.1 G/C 0.20 -3.14 ± 1.29 -1.09 ± 0.90 2.53 ± 0.67 1.48 9 10-6
rs4769524 13 GPR12 27377221 q12.13 A/G 0.08 n/a -0.56 ± 0.96 1.51 ± 0.61 2.78 9 10-6
rs1382566 8 BLK 11384841 p23.1 C/G 0.15 6.34 ± 3.91 2.69 ± 1.10 0.51 ± 0.62 2.30 9 10-6
African Americans
rs17191595 13 DIAPH3 58777413 q21.1 G/A 0.08 0.36 ± 6.14 3.26 ± 1.74 1.76 ± 0.72 1.55 9 10-6
rs1785581 18 TAF4B 23997267 q11.2 T/C 0.11 10.70 ± 3.57 6.76 ± 1.32 0.69 ± 0.73 2.98 9 10-6
rs11111146 12 CCDC53 102452264 q23.2 A/C 0.30 -1.73 ± 1.34 -0.25 ± 0.96 4.40 ± 0.98 2.21 9 10-6
Genes: LRRC61 leucine rich repeat containing 61, KLRAP1 killer cell lectin-like receptor subfamily A, pseudogene 1, MACROD2 MACRO
domain containing 2, GPR12 g protein-coupled receptor 12, BLK b lymphoid tyrosine kinase, DIAPH3 diaphanous homolog 3 (Drosophila),
TAF4B TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, CCDC53 coiled-coil domain containing 53
P values are based on the Fisher’s exact test for SNP association with antral follicle count. Bold values indicate genome-wide significance
a Minor/major allele
b The difference in mean (±SEM) number of follicles for a given genotype. ‘‘A’’ denotes the minor allele and ‘‘B’’ denotes the major allele
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This SNP was associated with mean increases of 1.8 ± 0.7
and 3.3 ± 1.7 follicles for the AA and AG genotypes,
respectively (Fig. 3; Table 3). Of the other two nominal
variants, rs1785581 at 18q11.2 is immediately downstream
of the TAF4b RNA Polymerase II, TATA Box Binding
Protein (TBP)-Associated Factor (TAF4B) gene, and was
associated with increases of 10.7 ± 3.6 and 6.8 ± 1.3
follicles for the TT and CT genotypes, respectively.
Rs11111146 at 12q23.2 is located in an intron of the
Coiled-Coil Domain Containing 53 (CCDC53) gene and
was associated with a decrease of 1.7 ± 1.3 and an
increase of 4.4 ± 1.0 follicles for the AA and CC geno-
types, respectively (Fig. 3; Table 3).
A comparison of loci associated with follicle number
and menopausal age indicates that several variants were
clustered in specific genomic regions on chromosomes 20,
13, and 12 (Online Resource Figure 3). The variants on
chromosome 20 including one associated with follicle
number in Caucasians (rs175810), one within MCM8
associated with both follicle number and menopause
(rs16991615), and several nearby associated variants, were
in a genomic region that comprises long stretches of highly
associated SNPs. Moreover, we found that many of the
identified variants associated with AFC were also associ-
ated with AMH (Online Resource Table 3; Fig. 5). Of the
top 16 variants associated with AFC, seven of these were
significantly associated with AMH levels, and again,
localized to chromosomes 12, 13 and 20.
MCM8 protein is expressed in human ovary
The presence of MCM8 in human ovary was determined by
immunohistochemistry and confocal and fluorescence
microscopy. Slide-mounted ovarian tissue sections from a
37-year-old woman showed a positive signal for the anti-
MCM8 antibody, visualized with the Alexa Fluor-488
secondary antibody (Fig. 4A–D). As shown in Fig. 4,
MCM8 colocalized with the germ cell-specific marker
VASA and was present within the oocytes of primordial,
primary, and secondary follicles. No specific staining was
observed with the rabbit and goat non-immune isotype IgG
controls using the same conditions and secondary anti-
bodies (negative control; Fig. 4E). MCM8 was detected at
low levels in peritubular cells, but not in developing sperm
(spermatocytes, spermatids, and sperm) in the seminiferous
tubules of the human testis (Fig. 4F). Further, MCM8 was
Fig. 3 Phenotypes and genotypes of SNPs associated with AFC. A,
B Shown in the left panels are scatter plots of the phenotypes of high
(H) and low (L) AFC separated by robust regression. a–c Also shown
is the distribution of genotypes among the women with respect to age
and AFC for the top SNPs in the A Caucasian and B African
American populations. The three genotypes are designated by blue,
orange and red points as indicated in the legends (parentheses
indicate the number of women with each genotype)
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not detected in terminally differentiated human neurons
(data not shown).
Phenotypes and covariates
Anthropometric and reproductive measurements were all
within the normal range and comparable to that of previous
data (Table 1). See Online Resources for a detailed
description of the population phenotypes and covariates. In
brief, the African American cohort had significantly shorter
height (P = 0.00035), greater weight (P = 2.54 9 10-21),
higher waist-hip (P = 1.02 9 10-18) and waist-height
(P = 2.47 9 10-31) ratios, and significantly greater BMI
(P = 1.58 9 10-27). Interestingly, in the analysis of frac-
tion of African ancestry, when controlling for female age
BMI was significantly associated with amount of African
ancestry (P = 0.014 and 0.012). Individuals with greater
African ancestry had significantly higher BMIs. However,
neither African ancestry nor BMI was associated with
follicle number (P = 0.57 and 0.81, respectively). A sig-
nificant proportion of the women had demonstrated fertility
with 36 and 52 % of the Caucasian and African American
women, respectively, having a parity of one or more chil-
dren, and the remainder having no indications of repro-
ductive disorders or infertility.
Discussion
We evaluated genetic associations with ovarian reserve and
validated variants associated with menopause, in an inde-
pendent cohort of women directly assessed for follicle
number. Our results indicate that there are underlying
variants/genes associated with both ovarian reserve and
menopause, providing more evidence for the connection
between these two traits. Importantly, we found one of
these genes, MCM8, is expressed within follicles of the
adult human ovary and is therefore an excellent candidate
Fig. 4 MCM8 is expressed in
human ovarian follicles.
A–D Immunodetection of the
germ cell marker VASA (red)
and MCM8 (green) in human
ovarian tissue, showing
colocalization in human oocytes
(yellow-orange; arrows indicate
primary and secondary follicles;
several primordial and primary
follicles also shown). E Lack of
immunostaining in ovarian
tissue incubated with rabbit and
goat non-immune isotype IgGs
in place of the primary
antibodies. F VASA and MCM8
expression in adult human testis
(arrowhead indicates
developing sperm with high
expression of VASA). For all
images DNA was stained with
DAPI (blue) (9200; insets show
specific VASA or MCM8
staining)
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gene for future studies of human oocyte development and
ovarian function. Our work carries population-level gen-
ome-wide findings to the cellular level and provides likely
functional evidence for a role of MCM8 in ovarian biology.
We also identified several additional SNPs associated with
follicle number in Caucasian and African American
women, with genetic loci that were validated in the dif-
ferent ethnic cohorts. These findings provide further evi-
dence for a genetic basis of the reproductive lifespan and
prospective markers and genes for future studies and
clinical diagnostics.
Because of the close association between ovarian
reserve and female fertility, as well as disease risk, studies
have investigated the ability of various non-invasive
markers to serve as proxies for ovarian reserve and pre-
dictors of reproductive potential. The ability to predict
oocyte loss and reproductive lifespan would enable
improved reproductive planning and health care decisions.
Our recent work examined genetic variants and envi-
ronmental factors associated with hormone markers of
ovarian reserve, including FSH and AMH (Schuh-Huerta
et al. 2012). As previously reported, there were several
variants associated with AMH or FSH, that were also
associated with follicle number; four out of the nine top
variants were validated for association with AFC. These
variants and genes linked with FSH and AMH, including
those also significantly associated with AFC are shown in
Fig. 5 (asterisks indicate overlapping genes). Because of
the close relationships between these serum hormone lev-
els, especially AMH, and total number of antral follicles,
this prompted a closer examination of specific genetic
factors associated with follicle number. The number of
preantral and antral follicles to a large extent drives serum
AMH levels, and therefore genetic associations with AMH
levels might in large part be driven by follicle number. And
this is indeed the case. Here, we report that many of the
identified variants associated with AFC are also associated
with AMH (Online Resource Table 3; Fig. 5). Of the top
16 variants associated with AFC, seven of these are sig-
nificantly associated with AMH levels, encompassing the
GPR12, KLRAP1, MACROD2, and BLK genes. Therefore,
there are both overlapping and independent genetic mark-
ers associated with follicle number and other accurate
markers of ovarian reserve.
AFC is considered one of the most reliable non-invasive
methods for determining the ovarian reserve. Antral folli-
cles are small (millimeters in diameter), fluid-filled struc-
tures that contain the developing oocytes and are visible by
ultrasound. The assumption that the number of antral fol-
licles is proportional to the total oocyte pool remaining in
the ovary is supported by histologic data (Hansen et al.
2008; Morris et al. 2002) and has led investigators to
compare the relationship between AFC and age (Broek-
mans et al. 2004; Faddy et al. 1992; Rosen et al. 2010b;
Scheffer et al. 1999). In mathematical models that exam-
ined reproductive events in non-contracepting populations,
AFC was predictive of age at natural fertility loss
(*10 years prior to menopause) and age at menopause
(Broekmans et al. 2004). AFC is also lower in infertile
women (Rosen et al. 2011). Our prior work detected great
variability in antral follicle count among Caucasian women
(Rosen et al. 2010b) and a lowered AFC associated with an
Fig. 5 Depiction of the development, maturation, and depletion of
the human female oocyte endowment and associated ovarian reserve
markers and candidate genes. Current work identifies AFC as a good
clinical marker and FSH and AMH as two good hormonal serum
markers of ovarian reserve. Shown in boxes are the identified genes
containing variants associated with AFC, FSH, AMH and menopause.
These represent novel candidate genes for future studies of human
ovarian function (asterisks indicate genes associated with two or more
ovarian reserve markers)
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earlier maternal age of menopause (Rosen et al. 2010a),
suggesting a strong genetic component to ovarian reserve.
Indeed, maternal age of menopause is a predictor for AFC
such that women whose mothers entered menopause ear-
lier, have lower AFCs at any given age (Rosen et al.
2010a). However, no previous studies have identified
genetic links with follicle number or between follicle
number and menopause.
Candidate gene and linkage association studies, mostly
in the context of reproductive disorders such as POF
(menopause before age 40), have identified a limited
number of genes and variants that may be associated with
the follicle pool and ovarian aging (Bretherick et al. 2008;
Fassnacht et al. 2006; Gromoll and Simoni 2005; Kevenaar
et al. 2007; Simpson 2008; Suzumori et al. 2007; Tung et al.
2006; Yoon et al. 2010). The X chromosome has a signif-
icant role in ovarian function. Monosomy X results in
women with Turner syndrome who have accelerated follicle
loss, degeneration of ovaries, and generally lack functional
oocytes, rendering them infertile (Fassnacht et al. 2006;
Turner 1972). Various forms of POF, in about 1–4 % of
women, are often familial and linked with genetic and
structural abnormalities of the X chromosome (Fassnacht
et al. 2006). However, in many POF cases, the underlying
genetic variants or mutations are unknown. Putative roles of
other female fertility genes have come from transgenic
mouse models and include various proteins and transcrip-
tion factors of oogenesis/folliculogenesis (Fassnacht et al.
2006; Knight and Glister 2006; Suzumori et al. 2007).
While POF is rare, the genetic variants responsible for the
normal variation in ovarian reserve (oocyte number) in the
general population have not been identified.
Recently, a few large-scale GWASs have discovered
SNPs associated with age of menarche (Elks et al. 2010; He
et al. 2009; Ong et al. 2009; Sulem et al. 2009) and age of
menopause (He et al. 2009; Murray et al. 2010; Stolk et al.
2009). In these large cohorts of post-menopausal European
women, several SNPs led to increases or decreases of about
3 months to 1 year in age at menopause, further implicat-
ing genetic factors in the timing of follicle loss. Meno-
pausal age is an indirect, retrospective marker of follicle
loss; direct measurements of follicle number were not
performed in these studies. Direct studies of follicle num-
ber and menopausal age in the same women have not been
possible. Moreover, most previous work has focused on
infertile populations, small observational studies, or post-
menopausal women. Much data are lacking on genetics and
reproductive parameters in women of reproductive age,
without ovarian disorders, and not seeking infertility
treatments. There is also little data on women of non-
European ancestry. Therefore, our community-based
cohort of reproductive-aged women of multiple ethnicities
is an ideal population to investigate genetic loci associated
with follicle number, and in combination with previous
cohorts, menopause. GWA studies in this population can
also determine whether additional specific variants may be
associated with ovarian reserve markers and various fer-
tility and somatic disorders in different ethnic groups.
We found that antral follicle number declined with
female age, showing a similar pattern in both Caucasian
and African American women, although with a trend for
slightly greater follicle counts, greater variability, and a
slower extrapolated rate of follicle loss in the African
Americans compared to Caucasians (0.76 vs. 0.93 follicles/
year, respectively). To our knowledge there are no other
publications on follicle number in fertile African American
women, so these results cannot be compared to any pre-
viously examined cohorts. It has been reported that African
American women may have an earlier age at menopause,
6–12 months sooner than Caucasians (Bromberger et al.
1997), while other studies have found no difference in
menopausal age between the two racial groups (Gold et al.
2001). Our results on follicle number indicate that this
African American population does not appear to have a
reduced ovarian reserve or increased risk for entering
menopause earlier than the Caucasian population.
There were many differences in anthropometric, hor-
monal, and reproductive assessments between the Cauca-
sian and African American women. The African American
women had greater average weight, shorter height, greater
BMI, an earlier age at menarche, greater parity, and several
other clinical/hormonal differences compared to the Cau-
casian cohort. In both ethnic groups, AFC was most closely
associated with serum levels of AMH and FSH, indepen-
dent of female age (Caucasians: R2 = 0.67 and -0.16,
respectively; African Americans: R2 = 0.49 and -0.14,
respectively; P \ 0.001). AMH levels increased and FSH
levels decreased with antral follicle count. While we found
that BMI was not associated with the total number of fol-
licles, interestingly BMI was associated with total fraction
of African ancestry. Although BMI and follicle counts
were higher in the African American cohort this cannot be
explained by higher rates of PCOS, as women with PCOS
and hyperandrogenism, as well as other reproductive dis-
orders were excluded. It is likely that many of these con-
founding variables, including ancestral genetic
background, may influence the oocyte pool, follicular
atresia, and reproductive lifespan, implicating several
causative factors in differences between racial groups.
To examine the hypothesis that the ovarian reserve and
reproductive lifespan are closely associated and affected by
multiple genetic factors, we tested the previously identified
variants associated with menopausal age in European
women, for association with follicle number, AMH and
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FSH in our population of women living in the US. We
found that variants in the region immediately flanking the
top menopausal SNP, rs16991615, were associated with
AMH and FSH, in both ethnic groups. Notably, the
majority of these variants were linked with AMH, FSH,
and/or AFC, and were replicated in both Caucasian and
African American women. Together, these results indicate
there are genetic associations underlying ovarian reserve
and menopausal age (reproductive lifespan) in women of
multiple ethnicities. We further found that directions and
magnitudes of the effects of all tested menopausal variants
were highly similar between age at menopause and follicle
number among the Caucasian women—variants associated
with later menopausal age were associated with higher
follicle counts and vice versa. There were ±0.3 to 1-year
differences in menopausal age, which were correlated with
±2 to 3-follicle differences in AFC, providing evidence
that these reproductive traits are functionally and geneti-
cally related. We found that variant rs16991615 within the
MCM8 gene was significantly associated with later meno-
pausal age of ?0.92 to 1.07 years in previous studies (He
et al. 2009; Murray et al. 2010; Stolk et al. 2009) and
greater follicle numbers of ?2.79 ± 1.67 follicles in the
Caucasian cohort of this study. This significant non-syn-
onymous SNP in exon 9 of MCM8 results in an amino acid
change from glutamic acid to lysine, which may alter
protein function.
MCM8 is a member of an evolutionarily conserved
family of proteins that are involved in whole genome
replication. However, MCM8 does not associate with the
other MCMs and likely has a role in DNA elongation (after
replication licensing). It is expressed in a variety of human
cell lines and tissues (Gozuacik et al. 2003) and localizes
specifically to the chromatin in the nucleus in S phase of
the cell cycle (Gozuacik et al. 2003; Maiorano et al. 2005).
Notably, the fly ortholog of MCM8, rec (recombination
defective), has a pivotal role in the formation of meiotic
crossovers during female gamete development with its loss
leading to chromosomal non-disjunction, aneuploidy and
diminished fertility (Blanton et al. 2005). Rec mutants are
specifically unable to copy enough DNA to form linkages
between chromosomes during egg meiosis. MCM8 is also
expressed in oocytes of the frog, Xenopus (Maiorano et al.
2005). Analysis of human EST databases indicates MCM8
may have moderate expression in both the developing
embryo and the ovary (http://www.ncbi.nlm.nih.gov/
UniGene), but there are no reports on the expression or
role of this highly conserved gene in human gametes.
We discovered that MCM8 is expressed within the
human ovary and colocalizes with the germ cell marker,
VASA, within the oocytes of several stages of follicle
growth. VASA is expressed specifically within germ cells
and developing oocytes and sperm and is therefore a good
marker of human oocytes. MCM8 was also expressed at
low levels in peritubular cells, but not in developing sperm
within the human testis. Interestingly, in some tissues
MCM family members are functionally regulated by
estrogen and progesterone (Pan et al. 2006), providing
another plausible link between MCMs and ovarian func-
tion. Taken together these findings present the first genetic
links underlying oocyte number and menopause. There
may be direct effects of MCM8 and other genes on oocyte
meiosis, development or depletion, and ultimately, meno-
pausal age providing a mechanism by which they influence
the reproductive lifespan. Future in vitro studies can
examine the functional roles of MCM8, as well as other
identified candidate genes in germ cell and follicle
development.
If a gene impacts the initial number of oocytes with
which a woman is endowed or their rate of depletion, that
gene might be expressed in oocytes, follicles and/or the
ovary and vary in the human population. Most of the
identified genes containing or near by the variants associ-
ated with AFC have no previously demonstrated roles in
female reproduction, but like MCM8, several are expressed
in the human ovary. LRRC61, proximal to the most sig-
nificant variant and associated with ?7 to 8 follicles,
encodes a protein-binding gene and is widely expressed,
with highest expression in the human ovary, cervix, and
adrenal gland. However, there has been no examination of
function in female biology. Other variants are within the
MACROD2 gene at 20p12.1 and nearby the KLRAP1 gene
at 12p13.2. Little is known about the function of MAC-
ROD2, although it appears to be expressed in several tis-
sues of the body including the ovary and testis. The TAF4B
gene, nearby an associated variant is expressed in granu-
losa cells of the follicle in both female mice and women
(Freiman et al. 2001; Wu et al. 2005). It is of interest that
TAF4B null mice are female infertile with defects in fol-
liculogenesis and oocyte maturation and resulting POF
(Lovasco et al. 2010) (Ovarian Kaleidoscope database:
http://ovary.stanford.edu/). Future functional studies
assessing gene expression and genetic silencing and over-
expression studies in female cell lines and ovarian tissues
are needed to explore the roles of these genes in human
oocyte biology.
As the ability of this work to validate many of the
variants associated with menopausal age, as well as dis-
cover new genome-wide variants associated with follicle
number is limited by sample size, future studies may aim
for validation of these findings. As this study is the first to
perform a GWA on antral follicle number in fertile, normo-
ovulatory women and also to examine multiple ethnic
groups, there are no other cohorts for independent valida-
tion. It is hoped that future work will collect data on AFC
to enable cross-validation and multi-site meta-analyses.
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In this and previous work we identify a set of candidate
genes that are associated with one or more of the human
ovarian reserve markers—AFC, AMH, FSH, and meno-
pause (Fig. 5). It is noteworthy that several variants asso-
ciated with both follicle number and menopause localized
to the same genomic regions of 20p12.1–12.3 and 13q
(Online Resource Figure 3). Our previous work found
common regions on 13q and 12p linked with several ovarian
reserve markers (Schuh-Huerta et al. 2012). Further, other
work has identified loci on chromosomes 13, 19, and 20 that
are associated with age at menopause (Stolk et al. 2009).
Therefore, these chromosomal regions and associated genes
may be hot spots for causative alleles or genes associated
with ovarian reserve and reproductive lifespan. Replication
of these findings in independent larger cohorts, as well as
longitudinal studies directly measuring follicle number over
time and the prospective onset of menopause in this cohort
could test the actual phenotypic and genotypic associations
between rates of follicle loss and entry into menopause
within the same population of women.
In conclusion, we present the first evidence for common
variants and new candidate genes underlying follicle
number (ovarian reserve), menopause, and the reproductive
lifespan. A better understanding of the genes and envi-
ronmental factors that impact ovarian reserve may provide
greater insight on the process of reproductive aging and the
genetic requirements of human fertility. Prediction of fol-
licle loss could ultimately enhance reproductive potential
and overall health. It is hoped that this work may help form
a foundation for clinical applications in identifying women
at risk for early ovarian failure and hence associated
reproductive and somatic diseases.
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